Log In
Tuesday 16th July 2019

Radiation-based prostate cancer drug approved

16th May 2013

A new injectable drug for advanced prostate cancer has been approved by the Food and Drug Administration (FDA).

The FDA said it approved the drug which uses radiation to treat prostate cancer that has spread to the bones.

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2019